387 related articles for article (PubMed ID: 15980151)
21. New Insights into the Disease Progression Control Mechanisms by Comparing Long-Term-Nonprogressors versus Normal-Progressors among HIV-1-Positive Patients Using an Ion Current-Based MS1 Proteomic Profiling.
Shen X; Nair B; Mahajan SD; Jiang X; Li J; Shen S; Tu C; Hsiao CB; Schwartz SA; Qu J
J Proteome Res; 2015 Dec; 14(12):5225-39. PubMed ID: 26484939
[TBL] [Abstract][Full Text] [Related]
22. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
23. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
Schneider T; Ullrich R; Zeitz M
Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
[TBL] [Abstract][Full Text] [Related]
24. Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect.
Epple HJ; Allers K; Tröger H; Kühl A; Erben U; Fromm M; Zeitz M; Loddenkemper C; Schulzke JD; Schneider T
Gastroenterology; 2010 Oct; 139(4):1289-300. PubMed ID: 20600014
[TBL] [Abstract][Full Text] [Related]
25. Systemic vaccination prevents the total destruction of mucosal CD4 T cells during acute SIV challenge.
Mattapallil JJ; Hill B; Douek DC; Roederer M
J Med Primatol; 2006 Aug; 35(4-5):217-24. PubMed ID: 16872285
[TBL] [Abstract][Full Text] [Related]
26. No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
López M; Soriano V; Lozano S; Ballesteros C; Cascajero A; Rodés B; De La Vega E; González-Lahoz J; Benito JM
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1185-95. PubMed ID: 18729773
[TBL] [Abstract][Full Text] [Related]
27. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA
AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635
[TBL] [Abstract][Full Text] [Related]
29. HIV disease progression: immune activation, microbes, and a leaky gut.
Douek D
Top HIV Med; 2007; 15(4):114-7. PubMed ID: 17720995
[TBL] [Abstract][Full Text] [Related]
30. The mucosal immune system and HIV-1 infection.
Veazey R; Lackner A
AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
[TBL] [Abstract][Full Text] [Related]
31. [Human immunodeficiency virus-1 gag specific CD8+ T cell responses in long-term nonprogressors and acquired immunodeficiency syndrome patients].
Zhang HW; Qiu ZF; Li TS
Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):911-4. PubMed ID: 15730736
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.
Cao W; Mehraj V; Vyboh K; Li T; Routy JP
AIDS Rev; 2015; 17(3):135-46. PubMed ID: 26450802
[TBL] [Abstract][Full Text] [Related]
33. [Protective immunity against HIV infection].
Takahashi H
Nihon Rinsho; 2002 Apr; 60(4):717-23. PubMed ID: 11968778
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.
Pernas M; Casado C; Sandonis V; Arcones C; Rodríguez C; Ruiz-Mateos E; Ramírez de Arellano E; Rallón N; Del Val M; Grau E; López-Vazquez M; Leal M; Del Romero J; López Galíndez C
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):225-31. PubMed ID: 23714744
[TBL] [Abstract][Full Text] [Related]
35. Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity.
Propato A; Schiaffella E; Vicenzi E; Francavilla V; Baloni L; Paroli M; Finocchi L; Tanigaki N; Ghezzi S; Ferrara R; Chesnut R; Livingston B; Sette A; Paganelli R; Aiuti F; Poli G; Barnaba V
Hum Immunol; 2001 Jun; 62(6):561-76. PubMed ID: 11390031
[TBL] [Abstract][Full Text] [Related]
36. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
Blankson JN; Gallant JE; Siliciano RF
J Infect Dis; 2001 Feb; 183(4):657-61. PubMed ID: 11170994
[TBL] [Abstract][Full Text] [Related]
37. Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.
Casado C; Marrero-Hernández S; Márquez-Arce D; Pernas M; Marfil S; Borràs-Grañana F; Olivares I; Cabrera-Rodríguez R; Valera MS; de Armas-Rillo L; Lemey P; Blanco J; Valenzuela-Fernández A; Lopez-Galíndez C
mBio; 2018 Apr; 9(2):. PubMed ID: 29636433
[TBL] [Abstract][Full Text] [Related]
38. Genetic and functional analysis of HIV type 1 nef gene derived from long-term nonprogressor children: association of attenuated variants with slow progression to pediatric AIDS.
Corró G; Rocco CA; De Candia C; Catano G; Turk G; Mangano A; Aulicino PC; Bologna R; Sen L
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1617-26. PubMed ID: 22583022
[TBL] [Abstract][Full Text] [Related]
39. Multiple Homozygous Variants in the STING-Encoding
Nissen SK; Pedersen JG; Helleberg M; Kjær K; Thavachelvam K; Obel N; Tolstrup M; Jakobsen MR; Mogensen TH
J Immunol; 2018 May; 200(10):3372-3382. PubMed ID: 29632140
[TBL] [Abstract][Full Text] [Related]
40. The immunology of HIV-infected long-term non-progressors--a current view.
Paroli M; Propato A; Accapezzato D; Francavilla V; Schiaffella E; Barnaba V
Immunol Lett; 2001 Nov; 79(1-2):127-9. PubMed ID: 11595299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
